官方服务：
资源简介：
Enriched GO processes of promoter gene regions using GOstats differentially methylated in the initial tumor vs recurrence.
应用场景：
创建时间：
2015-09-09
相关数据集
Supplementary Table 18/Figure 4 source data
Supplementary Table 18. Results from cell type proportion adjusted epigenome wide association study with CellDMC comparing embryonal tumors to non-tumor brain tissue.
Figshare2024-03-23 更新30
Table_3_m5C Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Papillary Thyroid Carcinoma.xls
Recently, immune response modulation at the epigenetic level is illustrated in studies, but the possible function of RNA 5-methylcytosine (m5C) modification in cell infiltration within the tumor micro
NIAID Data Ecosystem20
Epigenome analysis of a paraganglioma sample carrying the DLST-p.Y422C mutation [methylation array]. Epigenome analysis of a paraganglioma sample carrying the DLST-p.Y422C mutation [methylation array]
Genome wide DNA methylation profiling of a paraganglioma sample carrying the DLST-p.Y422C mutation. The Illumina Infinium EPIC Human DNA methylation Beadchip v1.2 was used to obtain a DNA methylation
NIAID Data Ecosystem10
Correlation between tumor methylation levels and clinical parameters.
Correlation between tumor methylation levels and clinical parameters.
NIAID Data Ecosystem20
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [ATAC-seq]. Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [ATAC-seq]
Chronic lymphocytic leukemia (CLL) is a genetically, epigenetically, and clinically heterogeneous disease. Despite this heterogeneity, the Bruton tyrosine kinase (BTK) inhibitor ibrutinib provides eff
NIAID Data Ecosystem20
